Nabiha Faisal, MD
Dr. Faisal is developing algorithms to identify cirrhosis using large administrative databases and will explore the epidemiology of cirrhosis in Manitoba. She will study the trends of alcohol and nonalcoholic fatty liver diseases and sociodemographic disparity.
Dr. Faisal has special interest in integrated health systems for advanced liver disease particularly those associated with alcohol and nonalcoholic liver diseases, the two most prevalent etiologies of liver diseases in the world. She is developing a collaborative care model supported by expertise from hepatology, addiction medicine and psychiatry to facilitate seamless access to addiction services for patients with alcohol liver disease, and improved health-related quality of life, with greater patient and provider satisfaction.
Dr. Faisal is an academic hepatologist, joined the University of Manitoba in 2019 as a clinician-investigator at an assistant professor level. She is currently enrolled in a Master's program in Community Health Sciences at University of Manitoba with anticipated completion next year. Dr. Faisal completed medical school and received her medical training in internal medicine and gastroenterology, hepatology at Dow Medical College, University of Karachi, Pakistan, one of Pakistan's premier university hospitals. After her training, she was recruited, as senior registrar to Liaquat National Hospital and Medical College, Karachi, Pakistan, where she worked as a gastroenterologist/hepatologist from 2009 until 2012.
From July 2012 to June 2014, Dr. Faisal completed a transplant hepatology fellowship at Toronto and served for an additional year as chief fellow. Dr. Faisal successfully engaged throughout her time in Toronto in clinical research, developed and conducted her own research projects including Pan Canadian multicenter studies on post-transplant treatment of recurrent hepatitis C. Her clinical interest focuses in the epidemiology of advance liver diseases in Manitoba with special interest in alcohol and nonalcoholic fatty liver diseases.
- Mitacs Research Award (2020)
- EASL Young Investigator Award (2015)
- Gold Medal - Best Research paper Pakistan Society of Gastroenterology (2011)